Abstract
Although existing evidence confirms that no pharmacologic agent ameliorates the decline in the lung function or changes the prognosis of chronic obstructive pulmonary disease (COPD), inhaled pharmacotherapy is a critical component of the management for patients suffering with COPD. Inhaled agents are directed to provide immediate relief of symptoms and to restore functional capacity in treatment of stable COPD. While COPD may not be cured, knowledge and implementation of currently available guidelines provide the health-care provider alternatives to treat the disease effectively. Respiratory therapists play an important role in the implementation of these guidelines, since they are often responsible for educating patients on the correct use of the inhalers. This paper reviews current evidence regarding the use of inhaled pharmacotherapy in the treatment of COPD and provides a guided approach to the use of different agents in stable COPD.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1058-1081 |
| Number of pages | 24 |
| Journal | Respiratory Care |
| Volume | 54 |
| Issue number | 8 |
| State | Published - Aug 2009 |
Fingerprint
Keywords
- β adrenergics
- Anticholinergics
- Chronic obstructive pulmonary disease
- COPD
- Global Initiative for Chronic Obstructive Lung Disease
- GOLD
- Guidelines
- Inhalation pharmacotherapy
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
- Critical Care and Intensive Care Medicine
Cite this
A stepwise approach to management of stable COPD with inhaled pharmacotherapy : A review. / Restrepo, Ruben D.
In: Respiratory Care, Vol. 54, No. 8, 08.2009, p. 1058-1081.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - A stepwise approach to management of stable COPD with inhaled pharmacotherapy
T2 - A review
AU - Restrepo, Ruben D.
PY - 2009/8
Y1 - 2009/8
N2 - Although existing evidence confirms that no pharmacologic agent ameliorates the decline in the lung function or changes the prognosis of chronic obstructive pulmonary disease (COPD), inhaled pharmacotherapy is a critical component of the management for patients suffering with COPD. Inhaled agents are directed to provide immediate relief of symptoms and to restore functional capacity in treatment of stable COPD. While COPD may not be cured, knowledge and implementation of currently available guidelines provide the health-care provider alternatives to treat the disease effectively. Respiratory therapists play an important role in the implementation of these guidelines, since they are often responsible for educating patients on the correct use of the inhalers. This paper reviews current evidence regarding the use of inhaled pharmacotherapy in the treatment of COPD and provides a guided approach to the use of different agents in stable COPD.
AB - Although existing evidence confirms that no pharmacologic agent ameliorates the decline in the lung function or changes the prognosis of chronic obstructive pulmonary disease (COPD), inhaled pharmacotherapy is a critical component of the management for patients suffering with COPD. Inhaled agents are directed to provide immediate relief of symptoms and to restore functional capacity in treatment of stable COPD. While COPD may not be cured, knowledge and implementation of currently available guidelines provide the health-care provider alternatives to treat the disease effectively. Respiratory therapists play an important role in the implementation of these guidelines, since they are often responsible for educating patients on the correct use of the inhalers. This paper reviews current evidence regarding the use of inhaled pharmacotherapy in the treatment of COPD and provides a guided approach to the use of different agents in stable COPD.
KW - β adrenergics
KW - Anticholinergics
KW - Chronic obstructive pulmonary disease
KW - COPD
KW - Global Initiative for Chronic Obstructive Lung Disease
KW - GOLD
KW - Guidelines
KW - Inhalation pharmacotherapy
UR - http://www.scopus.com/inward/record.url?scp=68549086902&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=68549086902&partnerID=8YFLogxK
M3 - Article
C2 - 19650947
AN - SCOPUS:68549086902
VL - 54
SP - 1058
EP - 1081
JO - Respiratory Care
JF - Respiratory Care
SN - 0020-1324
IS - 8
ER -